<ARTICLE> 5
<LEGEND>
                                             Financial Data Schedule
                                                IMMUCELL CORPORATION

     THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S UNAUDITED FINANCIAL STATEMENTS FOR THE ANNUAL PERIOD ENDED DECEMBER
31, 1998 AS REPORTED ON FORM 10-K AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.

</LEGEND>
       

                              
<PERIOD-TYPE>                    12-MOS
<FISCAL-YEAR-END>                DEC-31-1998
<PERIOD-END>                     DEC-31-1998

<CASH>                           1,538,905
<SECURITIES>                             0
<RECEIVABLES>                      293,304
<ALLOWANCES>                        43,550
<INVENTORY>                        475,949
<CURRENT-ASSETS>                 2,310,124
<PP&E>                           1,539,191
<DEPRECIATION>                     789,419
<TOTAL-ASSETS>                   3,144,847
<CURRENT-LIABILITIES>              443,902
<BONDS>                            453,349
<PREFERRED-MANDATORY>                    0
<PREFERRED>                              0
<COMMON>                         2,247,596
<OTHER-SE>                               0
<TOTAL-LIABILITY-AND-EQUITY>     3,144,847
<SALES>                          4,199,851
<TOTAL-REVENUES>                 4,481,867
<CGS>                            2,014,626
<TOTAL-COSTS>                    4,481,583
<OTHER-EXPENSES>                    55,585
<LOSS-PROVISION>                         0
<INTEREST-EXPENSE>                  45,217
<INCOME-PRETAX>                   (102,518)
<INCOME-TAX>                             0
<INCOME-CONTINUING>               (102,518)
<DISCONTINUED>                           0
<EXTRAORDINARY>                          0
<CHANGES>                                0
<NET-INCOME>                      (102,518)
<EPS-PRIMARY>                         (.04)
<EPS-DILUTED>                         (.04)